ETF Holdings Breakdown of ROIV

ROIV institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-29	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	229,848	USD 3,470,705
2025-09-29	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	41,391	USD 625,004
2025-09-29	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	387,213	USD 5,846,916 -0.5%
2025-09-29	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	387,213	USD 5,846,916
2025-09-29	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	2,690	USD 40,619 -0.5%
2025-09-29	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	2,791	USD 42,144 -0.5%
Total =		1,051,146	USD 15,872,304

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ROIV

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.38 Consensus Target Price from Analysts

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have earned a consensus recommendation of “Buy” from the five ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, two have given a buy recommendation and two have issued a strong buy […] - 2025-09-05 02:16:55

Mitsubishi UFJ Asset Management Co. Ltd. Has $173,000 Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)

Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 9.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,110 shares of the company’s stock after buying an additional 1,434 shares […] - 2025-08-15 04:46:57

Roivant Sciences (NASDAQ:ROIV) Shares Gap Down Following Weak Earnings

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) shares gapped down before the market opened on Monday following a weaker than expected earnings announcement. The stock had previously closed at $11.49, but opened at $10.90. Roivant Sciences shares last traded at $11.25, with a volume of 581,150 shares traded. The company reported ($0.31) earnings per […] - 2025-08-13 02:17:08

Roivant Sciences Ltd. (NASDAQ:ROIV) Position Lessened by Natixis Advisors LLC

Natixis Advisors LLC decreased its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 29.4% during the 1st quarter, HoldingsChannel reports. The firm owned 36,433 shares of the company’s stock after selling 15,187 shares during the period. Natixis Advisors LLC’s holdings in Roivant Sciences were worth $368,000 as of its most recent filing with […] - 2025-08-12 04:40:51

Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) CEO Eric Venker sold 100,000 shares of the stock in a transaction on Monday, July 21st. The shares were sold at an average price of $11.52, for a total value of $1,152,000.00. Following the sale, the chief executive officer owned 1,462,223 shares in the company, valued at […] - 2025-07-25 05:42:53

State of Michigan Retirement System Reduces Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

State of Michigan Retirement System cut its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 0.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 100,800 shares of the company’s stock after selling 900 shares during the quarter. State of Michigan Retirement System’s holdings in Roivant Sciences were worth $1,017,000 […] - 2025-07-16 05:42:59

Teacher Retirement System of Texas Has $989,000 Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Teacher Retirement System of Texas reduced its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 10.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 98,022 shares of the company’s stock after selling 11,509 shares during the quarter. Teacher Retirement System of Texas’ holdings in Roivant Sciences were worth […] - 2025-07-14 04:50:52

Roivant Sciences Ltd. (NASDAQ:ROIV) Stake Decreased by DAVENPORT & Co LLC

DAVENPORT & Co LLC lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 86.4% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 21,700 shares of the company’s stock after selling 138,440 shares during the quarter. DAVENPORT & Co LLC’s holdings in Roivant Sciences were worth $219,000 as of […] - 2025-07-09 05:48:58

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) Major Shareholder Sells $6,472,295.70 in Stock

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) major shareholder Vivek Ramaswamy sold 565,266 shares of the company’s stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $11.45, for a total transaction of $6,472,295.70. Following the transaction, the insider now owns 37,861,115 shares of the company’s stock, […] - 2025-06-26 05:22:55

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama trimmed its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 1.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 512,402 shares of the company’s stock after selling 9,822 shares during the quarter. Retirement […] - 2025-06-25 04:50:55

Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 16,400 Roivant Sciences Ltd. (NASDAQ:ROIV)

Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 16,400 shares of the company’s stock, valued at approximately $194,000. A number of other hedge funds and other institutional investors have […] - 2025-06-04 05:24:48

Roivant Sciences (NASDAQ:ROIV) Earns Buy Rating from HC Wainwright

Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 59.29% from the company’s previous close. Separately, Cantor Fitzgerald raised Roivant […] - 2025-05-30 02:16:45

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Vident Advisory LLC

Vident Advisory LLC boosted its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 98.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 32,039 shares of the company’s stock after acquiring an additional 15,918 shares during the period. Vident Advisory LLC’s holdings in Roivant Sciences were […] - 2025-05-28 05:26:49

Nuveen Asset Management LLC Decreases Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)

Nuveen Asset Management LLC reduced its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,013,533 shares of the company’s stock after selling 171,939 shares during the period. […] - 2025-05-21 05:58:57

468,010 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 468,010 shares of the company’s stock, valued at approximately $5,537,000. BNP Paribas Financial Markets owned 0.06% of Roivant Sciences […] - 2025-05-14 06:10:50

Federated Hermes Inc. Has $350,000 Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Federated Hermes Inc. trimmed its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 60.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,571 shares of the company’s stock after selling 45,152 shares during the period. Federated Hermes Inc.’s holdings in […] - 2025-04-18 04:58:54

Mitsubishi UFJ Asset Management Co. Ltd. Lowers Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Mitsubishi UFJ Asset Management Co. Ltd. lessened its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 9.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,676 shares of the company’s stock after selling 1,574 shares during the period. Mitsubishi UFJ Asset […] - 2025-04-04 05:19:16

84,091 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 84,091 shares of the company’s stock, valued at approximately $995,000. Several other institutional investors and hedge funds have also recently bought and sold shares of ROIV. GAMMA Investing […] - 2025-04-04 04:18:54

KLP Kapitalforvaltning AS Buys Shares of 77,600 Roivant Sciences Ltd. (NASDAQ:ROIV)

KLP Kapitalforvaltning AS purchased a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 77,600 shares of the company’s stock, valued at approximately $918,000. A number of other hedge funds and other institutional investors also recently made changes to their positions in […] - 2025-04-01 05:16:52

Thrivent Financial for Lutherans Decreases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)

Thrivent Financial for Lutherans lowered its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 101,056 shares of the company’s stock after selling 22,767 shares during the quarter. Thrivent Financial for Lutherans’ holdings in […] - 2025-04-01 04:38:48

Zurcher Kantonalbank Zurich Cantonalbank Grows Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 17.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 93,121 shares of the company’s stock after acquiring an additional 13,834 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s […] - 2025-03-20 06:16:47

Amundi Raises Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Amundi raised its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 15.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 337,515 shares of the company’s stock after purchasing an additional 44,019 shares during the quarter. Amundi’s […] - 2025-03-17 05:56:51

State of Michigan Retirement System Sells 1,900 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)

State of Michigan Retirement System lessened its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 1.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 101,700 shares of the company’s stock after selling 1,900 shares during the quarter. State of Michigan Retirement System’s holdings in Roivant Sciences were worth $1,203,000 as […] - 2025-03-10 05:41:09

Bank of New York Mellon Corp Buys 510,398 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)

Bank of New York Mellon Corp raised its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 17.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,439,540 shares of the company’s stock after acquiring an additional 510,398 shares during the period. Bank […] - 2025-03-07 07:05:01

Roivant Sciences (NASDAQ:ROIV) Upgraded to Strong-Buy at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of Roivant Sciences (NASDAQ:ROIV – Free Report) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $18.00 target price on shares of Roivant Sciences in a research report on Tuesday, February 11th. One research analyst has rated the stock […] - 2025-03-07 04:56:54

Mutual of America Capital Management LLC Has $4.25 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Mutual of America Capital Management LLC lowered its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 2.5% during the fourth quarter, Holdings Channel reports. The fund owned 358,819 shares of the company’s stock after selling 9,047 shares during the period. Mutual of America Capital Management LLC’s holdings in Roivant Sciences were […] - 2025-03-06 09:27:01

New York Life Investment Management LLC Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)

New York Life Investment Management LLC acquired a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 38,383 shares of the company’s stock, valued at approximately $454,000. Several other hedge funds have also added to or reduced their stakes in the stock. FMR LLC raised […] - 2025-03-05 08:11:25

Handelsbanken Fonder AB Has $1.34 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV)

Handelsbanken Fonder AB trimmed its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 40.9% in the 4th quarter, Holdings Channel reports. The fund owned 113,109 shares of the company’s stock after selling 78,300 shares during the quarter. Handelsbanken Fonder AB’s holdings in Roivant Sciences were worth $1,338,000 as of its most recent filing […] - 2025-02-27 07:57:06

Mirae Asset Global Investments Co. Ltd. Decreases Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)

Mirae Asset Global Investments Co. Ltd. cut its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,258 shares of the company’s stock after selling 2,489 shares during the period. […] - 2025-02-14 06:30:53

Roivant Sciences (NASDAQ:ROIV) Shares Gap Up Following Strong Earnings

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report)’s share price gapped up before the market opened on Monday after the company announced better than expected quarterly earnings. The stock had previously closed at $10.89, but opened at $11.41. Roivant Sciences shares last traded at $10.99, with a volume of 577,463 shares changing hands. The company […] - 2025-02-12 04:15:00

Back to Listing

Disclaimer